This biotech is halting its work with Novo Nordisk and laying off more people

Core Insights - Korro is reassessing its relationship with the Danish pharmaceutical company, indicating a potential shift in strategic partnerships within the industry [1] Company Analysis - The decision by Korro to rethink its ties suggests a broader trend among companies in the pharmaceutical sector to evaluate and possibly restructure their collaborations [1]